Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Archean Chemical Industries Ltd - 543657 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

 In terms of regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors ('Board') of Archean Chemical Industries Limited (the 'Company') through circular resolution approved the following on 26th May 2023 - 1. Amendment in Articles of Association of the Company subject to shareholder's approval. 2. Mr. R Raghunathan, Chief Financial Officer and Mr. G Arunmozhi, Company Secretary and Compliance Officer of the company have been authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchanges under regulation 30 of SEBI (LODR) regulations 2015. Their email id's are [email protected] and [email protected] and contact number is+91 44 61099999.
26-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, we enclose herewith disclosure of related party transactions, in the format as specified in the SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended 31st March, 2023.
26-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Submission Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31St March 2023 Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In terms of the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit- 1. Audited standalone and consolidated financial results for the quarter and year ended 31st March 2023. 2 Auditors'' Report (Standalone and Consolidated) for the quarter and financial year ended 31 March 2023. 2. Declaration pursuant to regulation 33(3)(d) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended.
26-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Board Meeting Outcome for Outcome Of Board Meeting Held On 26Th May 2023 As Per Regulation 30 Read With Part A Of Schedule III Of SEBI (LODR) Regulations 2015

 In terms of regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that at the meeting of the Board of Directors ('Board') of Archean Chemical Industries Limited (the 'Company') held today, i.e 26th May 2023, the Board has transacted, inter alia, the following- 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2023 as per Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015. The aforesaid financial results along with the Auditors Report and Declaration in respect of Audit Reports with unmodified opinion are enclosed as Annexure - 1; 2. Recommended a final dividend of Rs 2.50 per equity share of Rs.2/- each (125%) for the financial year ended 31st March, 2023, subject to the approval of shareholders. The Board Meeting commenced at 05.00 pm and concluded at 07.55 pm.
26-05-2023
Bigul

Annual report for Archean Chemical Industries Ltd. for FY-2023
26-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and year ended 31st March 2023, is scheduled on Monday, 29th May 2023 at 12.00 noon IST.
24-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and year ended 31st March 2023, is scheduled on Monday, 29th May 2023 at 12.00 noon IST.
24-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015.

 Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2023 and to consider and recommend dividend, if any, for the financial year ended 31st March, 2023.
19-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended 31st March 2023, issued by ICRA Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company.
15-05-2023
Bigul

Archean Chemical Industries Ltd - 543657 - Statement Of Deviation / Variation In Utilization Of Funds Raised Through IPO For The Quarter Ended 31St March 2023 Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended 31st March 2023 in the prescribed format. We confirm that, as at 31st March 2023, there has not been any deviation(s) or variation(s) in the utilization of net proceeds of IPO as mentioned in the objects stated in the Prospectus dated 14th November 2022.
15-05-2023
Next Page
Close

Let's Open Free Demat Account